PUBLIC COMPANY
saveRise Therapeutics LLC
updated 2mo ago
community read0 votes
pipeline
3
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(3)
pipeline depth3 products
3Phase 1
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase1A Repeat Ascending Dosing Study of the Safety and Clinical Activity of R-3750 in Patients With Mild to Moderate COPD
- phase1R-3750 in Patients With Mild to Moderate Ulcerative Colitis
- phase1R-5280 in Newly Diagnosed Patients With Type 1 Diabetes
- phase1R-2487 in Patients With Rheumatoid Arthritis
- phase1R-2487 in Patients With Sjogren's Syndrome (SS)
- phase1R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that